Summary
During the past 8 years there has been substantial progress in our understanding of the structure, distribution and action of endogenous opioid peptides. Currently, there appear to be 2 groups of peptides; those derived from β-lipotropin and an enkephalin-related group. Some of these peptides have been shown to be distributed widely in the central nervous system and in endocrine tissues. The activity of the peptides probably occurs at several receptors but only 1 relatively specific (μ-receptor) antagonist, naloxone, is well studied. Although there have been many clinical studies of the action of opioids in man, no novel therapeutic applications have yet been established in clinical practice.
Of the many areas of involvement attributed to opioids, those of analgesia, reproductive endocrinology, opiate dependence, and certain as yet undefined subtypes of major psychoses seem reasonably promising. Speculation surrounding opioid involvement in other disorders such as spinal trauma, septic shock, alcohol dependence, ‘functional’ gastrointestinal disease, diabetes and asthma is of considerable interest but is supported by less clinical evidence.
It seems that as research in opioids advances, the putative physiological opioid ‘spheres of influence’ widen. At the same time, opioid mechanisms of action are being revealed to be more subtle and complex than previously thought. As a consequence, the expectations of rapid therapeutic application of opioid peptides and their antagonists are being modified and refined and realistic research strategies applied. In view of the work reviewed in this paper it seems reasonable to expect that such work will pay dividends in the not too distant future.
Similar content being viewed by others
References
Aghajanian, G.K.: Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276: 186–188 (1978).
Amaho, K.: Rostral mesencephalic reticulotomy for pain relief. Report of 15 cases. Acta Neurochirurgica Supplementum (Wien) 30: 391–393 (1980).
Ambinder, R.F. and Schuster, M.M.: Endorphins: New gut peptides with a familiar face. Gastroenterology 77: 1132–1140 (1979).
Azizi, F.; Vagenakis, A.; Longcope, C; Ingbar, S.H. and Braverman, L.E.: Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 22: 467–472274 (1973).
Baskin, D.S. and Hosobuchi, Y.: Naloxone reversal of ischaemic neurological deficits in man. Lancet 2: 272–275 (1981).
Beaumont, A. and Hughes, J.: Biology of opioid peptides. Annual Review of Pharmacology and Toxicology 19: 245–267 (1979).
Berger, P.A.; Watson, S.J.; Akil, H.; Elliott, G.R.; Rubin, R.T.; Pfefferbaum, A.; Davis, K.L.; Barchas, J.D. and Li, C.H.: β-Endorphin and schizophrenia. Archives of General Psychiatry 37: 635–640 (1980).
Bergland, R.M. and Page, R.B.: Can the pituitary secrete directly to the brain? Endocrinology 102: 1325–1338 (1978).
Bisset, G.W.; Chaudrey, H.S. and Feldberg, W.: Release of vasopressin by enkephalin. Brit. J. Pharmacol. 62: 370–371 (1978).
Blankstein, J.; Reyes, F.I.; Winter, J.S.D. and Faiman, C.: Endorphins and the regulation of the human menstrual cycle. Clinical Endocrinology 14: 287–294 (1981).
Bloom, F.; Segal, D.; Ling, N. and Guillemin, R.: Endorphins: Profound behavioural effects in rats suggest new etiological factors in mental illness. Science 194: 630–632 (1976).
Blum, K.; Futterman, S.; Wallace, J.E. and Schwertner, H.A.: Naloxone-induced inhibition of ethanol dependence in mice. Nature 265: 49–51 (1977).
Boureau, F.; Willer, J.C. and Yamaguchi, Y.: Abolition par la naloxone de l’effet inhibiteur d’une stimulation electrique peripherique sur la composente tardive dur reflexe de clignement. Electroencephalography and Clinical Neurophysiology 47: 322–328 (1979).
Brambilla, F.; Sanhetti, E. and Brunetta, M.: Pituitary-gonadal function in heroin addicts. Neuropsychobiology 3: 65–74 (1977).
Brandt, N.J.; Terenius, L.; Jacobsen, B.B.; Klinken, L.; Nordius, A.; Brandt, S.; Blegvad, K. and Yssing, M.: Hyper-endorphin syndrome in a child with necrotizing encephalopathy. New England Journal of Medicine 303: 914–916 (1980).
Bruni, J.F.; Watkins, W.B. and Yen, S.S.C.: β-Endorphin in the human pancreas. Journal of Clinical Endocrinology and Metabolism 49: 649–651 (1979).
Carenzi, A.; Guidotti, A.; Revuelta, A. and Costa, E.: Molecular mechanisms in the morphine and viminol (R2) on rat striaturn. J. of Pharmacol. Exp. Therap. 194: 311–318 (1975).
Chang, K. and Cuatrecasas, P.: Heterogeneity and properties of opiate receptors. Federation Proceedings 40: 2729–2733 (1981).
Chavkin, C. and Goldstein, A.: Specific receptor for the opioid peptide dynorphin: Structure-activity relationships. Proc. Nat. Acad. Sci. USA 78: 6543–6547 (1981).
Chernick, V.; Madansky, D.L. and Lawson, E.E.: Naloxone decreases the duration of primary apnea with neonatal asphyxia. Pediatrie Research 14: 357–359 (1980).
Childers, S.R.; Simantov, R. and Snyder, S.H.: Enkephalin: Radioimmunoassay and radioreceptor assay in morphine dependent rats. European Journal of Pharmacology 46: 289 (1977).
Cicero, T.J.: Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male. Federation Proceedings 39: 2551–2554 (1980).
Clement-Jones, V.; Lowry, P.J.; Rees, LH. and Besser, G.M.: Metenkephalin circulates in human plasma. Nature 283: 295–297 (1980a).
Clement-Jones, V.; McLoughlin, L.; Tomlin, S.; Besser, G.M.; Rees, L.H. and Wen, H.L.: Increased β-endorphin but not metenkephalin levels in human CSF after acupuncture for recurrent pain. Lancet 2: 946–948 (1980b).
Funder, J.W.; Clements, J.A.C.; Tracy, K. et al.: ACTH, βendorphin and β-lipotropin in normal thyroid and lung: Possible implications for ectopic hormone secretion. Endocrinology (Submitted for publication, 1983).
Cohen, S.I.; Bondurant, S. and Silverman, A.J.: Psychophysiological influences on peripheral venous tone. Psychosomatic Medicine 22: 106–117 (1960).
Collins, M.A.; Nijm, W.P.; Borge, G.P.; Teas, G. and Goldfard, C: Dopamine-related tetrahydroisoquinolines: Significant urinary excretion by alcoholics after alcohol consumption. Science 206: 1184–1186 (1979).
Comford, E.M.; Braun, L.D.; Crane, P.D. and Oldendorf, W.H.: Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology 103: 1297 (1978).
Csontos, K.; Rust, M; Hollt, V.; Mahr, W.; Kromer, W. and Teschemacher, H.J.: et al.: Elevated plasma β-EP levels in pregnant women and their neonates. Life Sciences 25: 835–844 (1979).
Czech, D.A. and Stein, E.A.: Naloxone depresses osmoregulatory drinking in rats. Pharmacology Biochemistry and Behaviour 12: 987–989 (1980).
Davis, G.C.; Buschsbaum, M.S. and Bunney, W.I.: Research in endorphins and schizophrenia. Schizophrenia Bulletin 5: 244–250 (1979).
Davis, V.E. and Walsh, M.J.: Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction. Science 167: 1005–1007 (1970).
Delitala, G.; Devilla, L. and Arata, L: Opiate receptors and anterior pituitary hormone secretion in man. Effects of naloxone infusion. Acta Endocrinologica 97: 150–156 (1981).
de Wied, D.; Bohus, B.; van Ree, J.M.; Kovacs, G.L. and Greven, H.M.: Neuroleptic-like activity of [des-Tyr1]-γ-endorphin in rats. Lancet 1: 1046 (1978).
Diaz-Buxo, J.A.; Caudle, J.A.; Chandler, J.T.; Farmer, C.E. and Holbrook, W.D.: Dialysis of schizophrenic patients: A double-blind study. American Journal of Psychiatry 137: 1220 (1980).
Domschke, W.; Dickschas, A. and Mitznegg, P.: CSF beta-endorphin in schizophrenia. Lancet 1: 1024 (1979).
Dorsa, D.M.; de Kloet, E.R.; Mezey, E. and deWied, D.: Pituitary-brain transport of neurotensin: Functional significance of retrograde transport. Endocrinology 104: 1663–1666 (1979).
Editorial: Pituitary ablation for pain relief. Lancet 1: 1348–1349 (1981).
El-Sobky, A.; Dostrovsky, J.O. and Wall, P.D.: Lack of effect of naloxone on pain perception in humans. Nature 263: 783–784 (1976).
Emrich, H.M.; Hollt, V.; Kissling, W.; Fischler, M.; Lapse, H.; Heinemann, H.; von Zerssen, D. and Herz, A.: Beta-endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders. Pharmakopsychiatrica Neuropsychopharmakologica 12: 267–276 (1979).
Emrich, H.M.; Zandig, M.; Van Zerssen, D.; Herz, A. and Kissling, W.: Des-Tyr1-γ-Endorphin in schizophrenia. Lancet 2: 1364–1365 (1980).
Emrich, H.M.; Vogt, P. and Herz, A.: Possible antidepressive effects of opioids - action of buprenorphine. Annals of the New York Academy of Sciences 398: 108–112 (1982).
Faden, A.I.; Jacobs, T.P.; Mougey, E. and Holaday, J.W.: Endorphins in experimental spinal injury: Therapeutic effect of naloxone. Annals of Neurology 10: 326–332 (1981).
Farber, J.P. and Maltby, M.A.: Ventilatory effects of naloxone and morphine in the developing oppossum. Respiratory Physiology 41: 279–287 (1980).
Finkelstein, F.N.; Bayre, L.H. and Ragno, R.E.: Nonspecific arousal with naloxone. Canadian Medical Association Journal 123: 33–35 (1980).
Fletcher, J.E.; Thomas, T.A. and Hill, R.G.: β-EP and parturition. Lancet 1: 310 (1980).
Foley, K.M.; Kourides, I.A.; Inturrisi, C.E.; Kaiko, R.F.; Zarovlis, CG.; Posner, J.B.; Houde, R.W. and Li, C.H.: β-Endorphin: Analgesic and hormonal effects in humans. Proceedings of the National Academy of Science USA 76: 5377–5381 (1979).
Fraioli, F.; Moretti, C; Paolucci, D.; Alicicco, F.; Crescenzi, F. and Fortunio, G.: Physical exercise stimulates marked concomitant release of β-endorphin and adrenocorticotropic hormone (ACTH) in peripheral blood in man. Experientia (Basel) 36: 987–989 (1980).
Fratta, W.; Yang, H.Y.; Hong, J. and Costa, E.: Stability of metenkephalin content in brain structures of morphine-dependent or foot shock stressed rats. Nature 268: 452–453 (1977).
French, H.D.; Porter, R.W.; Cavanaugh, E.B. and Longmire, R.L.: Experimental gastroduodenal lesions induced by stimulation of the brain. Psychosomatic Medicine 19: 209–220 (1957).
Frenk, H.; Urea, G. and Liebskind, J.C.: Epileptic properties of leucine and methionine enkephalin: Comparison with morphine and reversibility with naloxone. Brain Research 147: 327–337 (1978).
Gaildcn, E.C.; Littlefield, D.C.; Putoff, O.C. and Seivert, A.L.: Menstrual abnormalities associated with heroin addiction. American Journal of Obstetrics and Gynecology 90: 155–159 (1964).
Gcnazzani, A.R.; Facchinetti, F. and Parrini, D.: β-Lipotropin and β-endorphin plasma levels during pregnancy. Clinical Endocrinology 14: 409–418 (1981).
Gerncr, R.H.; Catlin, D.H.; Gorelick, D.A.; Hui, K.K. and Li, C.H.: β-Endorphin. Intravenous infusion causes behavioural change in psychiatric inpatients. Archives of General Psychiatry 37: 642–647 (1980).
Gjessing, J. and Tomlin, P.J.: Post-operative pain control with intrathecal morphine. Anaesthesia 36: 268–276 (1981).
Gold, M.S.; Redmond, D.E. Jr and Kleber, H.D.: Clonidine blocks acute opiate-withdrawal symptoms. Lancet 2: 599–602 (1978).
Gold, M.S.; Pottash, A.L.C.; Annitto, W.J. et al.: Lofexidine blocks acute opiate withdrawal. Society for Neuroscience, Abstract 238.4, 11th Annual Meeting (1981).
Goldstein, A.; Lowney, L.I. and Pal, B.K.: Stereospecific and nonspecific interactions of the morphine narcotic congener levorphanol in subcellular fractions of mouse brain. Proceedings of the National Academy of Science USA 68: 1742–1747 (1971).
Goldstein, A.; Pryor, G.T.; Otis, L.S. and Larsen, F.: On the role of endogenous opioid peptides: Failure of naloxone to influence shock escape threshold in the rat. Life Sciences 18: 599–604 (1976).
Golstein, J.; Cantraine, F.; Copinschi, G.; L’Hermite, M.; Pipeleers, D.; Robyn, C; Velkeniers, B. and Vanhaelst, B.: Effects of enkephalins infusion on hormonal levels in man: Inhibition of the episodic secretion of LH by met-enkephalin. IRCS Medical Science 9: 218–219 (1981).
Grandison, L. and Guidotti, A.: Evidence for regulation of prolactin release by endogenous opiate. Nature 270: 357–359 (1977).
Greenwald, J.E.; Fertel, R.H., Wong, L.K.; Schwarz, R.D. and Bianchine, J.R.: Salsolinol and tetrahydropapaverine bind opiate receptors in the rat brain. Federation Proceedings 38: 379 (1979).
Guillemin, R.; Ling, N. and Burgus, R.: Endorphins, peptides d’origine hypothalamique et neurohypophysaire a activite morphinometique. Isolement et structure moleculaire d’α-endorphin. C.R. Academie Science [D] (Paris) 282: 783–785 (1976).
Hamilton, M.G.; Hirst, M. and Blum, K.: Opiate-like activity of salsolinol on the electrically stimulated guinea pig ileum. Life Sciences 25: 2205–2210 (1979).
Heel, R.C.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Buprenophrine: A review of its pharmacological properties and therapeutic efficacy. Drugs 17: 81–152 (1979).
Hendrikscn, S.J.; Bloom, F.E.; McCoy, F.; Ling, N. and Guillemin, R.: β-Endorphin induces nonconvulsive limbic seizures. Proceedings of the National Academy of Science USA 75: 5221–5225 (1978).
Herkenham, M. and Pert, C: In vitro autoradiography of opiate receptors in rat brain suggests loci of “opiatergic” pathways. Proceedings of the National Academy of Science USA 77: 5532–5536 (1980).
Herz, A.; Hollt, R.; Przewlocki, H.; Osborne, H.; Gramsch, C. and Duka, T.: Functional aspects of endorphins. Progress in Biochemical Pharmacology 16: 11–21 (1980).
Hiller, J.M. and Simon, E.J.: Specific high affinity [3H]ethyl-ketocyclazocine binding in rat central nervous system: Lack of evidence for K receptors. Journal of Pharmacology and Experimental Therapeutics 21: 516–519 (1980).
Ho, W.K.; Wen, H.L. and Ling, N.: Beta-endorphin-like immunoactivity in the plasma of heroin addicts and normal subjects. Neuropharmacology 19: 117–120 (1980).
Holaday, J.W. and Faden, A.I.: Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Research 189: 295–299 (1980).
Holaday, J.W., Wei, E.; Loh, H.H. and Li, C.H.: Endorphins may function in heat adaptation. Proceedings of the National Academy of Science USA 75: 5221–5225 (1978).
Hope, J. and Lowry, P.J.: Pro-opiocortin: The ACTH/LPH common precursor protein; in Van Wimersma and Greidanus (Eds) Frontiers of Hormone Research Vol. 8, pp. 44–61 (Karger, Basel 1981).
Hosobuchi, Y.; Adams, J.E. and Linchitz, R.: Pain relief by electrical stimulation of the central grey matter in humans and its reversal by naloxone. Science 197: 183–186 (1977).
Hosobuchi, Y.; Baskin, D.S. and Woo, S.K.: Reversal of induced ischemie neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215: 69–70 (1982).
Houck, J.C.; Kimball, C; Chang, C; Pedigo, N.W. and Yamamura, H.I.: Placental β-endorphin-like peptides. Science 207: 78–80 (1980).
Hughes, J.: Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Research 88: 293–308 (1975).
Hughes, J.; Kosterlitz, H.W. and Smith, T.W.: The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. British Journal of Pharmacology 61: 639–647 (1977).
Hughes, J.; Smith, T.W.; Kosterlitz, H.W.; Fothergill, L.A.; Morgan, B.A. and Morris, H.R.: Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258: 577–579 (1975).
Imura, H. and Nakai, Y.: ‘Endorphins’ in pituitary and other tissues. Annual Review of Physiology 43: 265–278 (1981).
Ipp, E.; Dobbs, R.E. and Unger, R.H.: Morphine and β-endorphin influence the secretion of the endocrine pancreas. Nature 276: 190–191 (1978).
Iversen, L.L.; Iversen, S.D. and Bloom, F.E.: Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis. Nature 284: 350–351 (1980).
Jacob, J.J.; Tremblay, E.C. and Colombel, M.C.: Facilitation de reactions nocioceptives par la naloxone chez la souris et chez le rat. Psychopharmacologia 37: 217–223 (1974).
Jacquet, Y.F. and Marks, N.: The C-fragment of beta-lipotropin: An endogenous neuroleptic or antipsychotogen. Science 194: 632–636 (1976).
Jaffe, J.H. and Martin, W.R.: Opioid analgesics and antagonists; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, 6th edition, pp. 393–423 (MacMillan, New York 1980).
Jasinski, D.R.; Pevnick, J.S. and Griffiths, J.P.: Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Archives of General Psychiatry 35: 501 (1978).
Kastin, A.J.; Nissen, C; Schally, A.V. and Coy, D.H.: Blood-brain barrier, half-time disappearance, and brain distribution for labelled enkephalin and a potent analog. Brain Research Bulletin 1: 583–589 (1976).
Kato, Y.; Iwasaki, Y.; Abe, H.; Ohgo, S. and Imura, H.: Effects of endorphins on prolactin and growth hormone secretion in rats. Proceedings of the Society for Experimental Biology and Medicine 158: 431–436 (1978).
Kilpatrick, D.L.; Taniguchi, T.; Jones, B.N.; Stern, A.S.; Shively, J.E.; Hullihan, K.; Kimura, S.; Stein, S. and Udenfriend, S.: A highly potent 3200 dalton adrenal opioid peptide that contains both a [Met]- and [Leu]-enkephalin sequence. Proceedings of the National Academy of Science USA 78: 3265–3268 (1981).
Kline, N.S.; Li, C.H.; Lehmann, H.E.; Latja, A.; Laski, E. and Cooper, T.: Beta-endorphin induced changes in schizophrenic and depressed patients. Archives of General Psychiatry 34: 1111–1113 (1977).
Kolata, G.: New theory of hormones proposed. Science 215: 1383–1384 (1982).
Konturek, S.J.; Pawlick, W.; Tasler, J.; Thor, P.; Walus, K.; Krol, R.; Jaworek, S. and Schally, A.V.: Effects of enkephalin on the gastrointestinal tract; in Bloom (Ed.) Gut Hormones, pp. 507–514 (Churchill Livingstone, New York 1978).
Kosterlitz, H.W.: Possible functions of the enkephalins; in Costa and Trabucchi (Eds) Neural Peptides and Neuronal Communication, pp. 633–642 (Raven Press, New York 1980).
Kosterlitz, H.W. and Hughes, J.: Some thoughts on the significance of enkephalin, the endogenous ligands. Life Sciences 17: 91–96 (1975).
Kosterlitz, H.W. and Hughes, J.: Peptides with morphine-like action in the brain. British Journal of Psychiatry 130: 298–304 (1977).
Kosterlitz, H.W.; Paterson, S.J. and Robson, L.E.: Opioid peptides and their receptors; in Fink and Whalley (Eds) Neuropeptides: Basic and Clinical Aspects, pp. 3–12 (Churchill-Livingston, Edinburgh 1982).
Kreuger, H.: The action of morphine on the digestive tract. Physiological Reviews 17: 619–645 (1937).
Kuschinsky, K. and Hornikiewicz, K.: Morphine catalepsy in the rat: Relation to striatal dopamine metabolism. European Journal of Pharmacology 19: 119–122 (1972).
La Mont, J.T. and Isselbacher, K.J.: Diseases of the colon and rectum; in Isselbacher et al. (Eds) Harrison’s Principles of Internal Medicine, pp. 1419–1437 McGraw-Hill, New York 1980).
Le Magnen, J.; Marfaing-Jallat, P.; Miceli, D. and Devos, M.: Pain modulating and reward systems: A single brain mechanism? Pharmacology Biochemistry and Behaviour 12: 729–733 (1980).
Leslie, R.D.G.; Pyke, D.A. and Stubbs, W.A.: Sensitivity to enkephalin as a cause of non-insulin dependent diabetes. British Medical Journal 2: 1521–1522 (1978).
Leslie, R.D.G.; Bellam, D. and Pyke, D.A.: Asthma induced by enkephalin. British Medical Journal 1: 16–18 (1980).
Levine, J.D.; Gordon, N.C.; Jones, R.T. and Fields, H.L.: The narcotic antagonist naloxone enhances clinical pain. Nature 272: 826–827 (1978a).
Levine, J.D.; Gordon, N.C. and Fields, H.C.: The mechanism of placebo analgesia. Lancet 2: 654–657 (1978b).
Lewis, R.V.; Gerber, L.D.; Stein, S.; Stephen, R.L.; Grosser, B.I.; Velick, S.F. and Udenfriend, S.: On beta H-Leu-5-endorphin and schizophrenia. Arch. Gen. Psych. 36: 237–239 (1979).
Li, C.H. and Chung, P.: Isolation and structure of an untriakointapeptide with opiate activity from camel pituitary glands. Proceedings of the National Academy of Science USA 773: 1145–1148 (1976).
Lightman, S.L.: Opiate receptors and the menopause; in Jewell (Ed.) Advanced Medicine, No. 17, pp. 206–218 (Pitman, London 1981).
Lightman, S.L.; Jacobs, H.S.; Maguire, A.K. et al.: Constancy of opioid control of luteinizing hormone in different pathophysiological states. Journal of Clinical Endocrinology and Metabolism 52: 1260–1263 (1981).
Linkowski, P.; Vanherweghen, J.L.; Jadot, C. and Mendlewicz, J.: Haemodialysis in schizophrenia. Lancet 2: 1381 (1979).
Lipton, S.; Miles, J.; Williams, N. and Bark-Jones, N.: Pituitary injection of alcohol for widespread cancer pain. Pain 5: 73–82 (1978).
Long, D.M.: Relief of cancer pain by surgical and nerve blocking procedures. Journal of the American Medical Association 244: 2759–2761 (1980).
Mackenzie, A.I.: Naloxone in alcohol intoxication. Lancet 1: 733–734 (1979).
Magee, D.F.: Action of morphine sulphate on stimulated gastric secretion in dogs. Gastroenterology 68: 1340–1343 (1975).
Margules, D.L.; Moisset, B.; Lewis, M.J.; Shibuya, H. and Pert, C.B.: Beta-endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science 202(4371): 988–991 (1978).
Marx, J.: Brain opiates in mental illness. Science 214: 1013–1015 (1981).
Mayer, D.J.; Pryce, D.D. and Rafii, A.: Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Research 121: 360 (1977).
Meites, J.; Bruni, J.F.; van Vugt, D.A. and Smith, A.V.: Relation of endogenous opioid peptides and morphine to neuroendocrine functions. Life Sciences 24: 1325 (1979).
Mendelson, J.H.; Mendelson, J.E. and Patch, V.D.: Plasma testosterone in heroin addiction and during methadone maintenance. Journal of Pharmacology and Experimental Therapeutics 142: 211–217 (1975).
Metz, J.; Busch, D.A. and Meltzer, H.Y.: Clinical, electrophysiological and biochemical effects of Des-tyrosine-γ-endorphin in psychiatric patients. Annals of the New York Academy of Sciences 398: 496–509 (1982).
Misra, A.L.: Metabolism of opiates; in Adler et al. (Eds) Factors Affecting the Action of Narcotics, pp.297–343 (Raven Press, New York 1978).
Moricca, G.: The management of cancer pain; in Progress in Anaesthesiology. Proceedings of the 4th World Congress of Anaesthesiology, pp. 266–270 (Excerpta Medica, Amsterdam 1968).
Morley, J.E.: The endocrinology of the opiates and opioid peptides. Metabolism 30: 195–209 (1981).
Morley, J.E.; Baranetsky, N.G.; Wingert, T.D.; Carlson, H.E.; Hershman, J.M.; Melmed, S.; Levin, S.R.; Jamison, K.R.; Weitzman, R.; Chang, R.J. and Varner, A.A.: Endocrine effects of naloxone-induced opiate receptor blockade. Journal of Clinical Endocrinology and Metabolism 50: 251–257 (1980).
Moroni, F.; Cheney, D.L. and Costa, E.: Beta endorphin inhibits ACh turnover in nuclei of rat brain. Nature 267: 267–268 (1977).
Myers, R.D. and Melchior, C.L.: Alcohol drinking: Abnormal intake caused by tetrahydropapaveroline in brain. Science 196: 554–556 (1977).
Naber, D.; Pickar, D.; Post, R.M.; Van Kammen, D.P.; Waters, R.N.; Ballenger, J.C.; Goodwin, F.K. and Bunney, W.E.: Endogenous opioid activity and β-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. American Journal of Psychiatry 138: 1457–1462 (1981).
Nakanishi, S.; Inoue, A.; Kita, T.; Nakamura, M.; Chang, A.C.Y.; Cohen, S.N. and Numa, S.: Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor. Nature 278: 423–427 (1979).
Nakao, K.; Nakai, Y.; Oki, S.; Horii, K. and Imura, H.: Presence of immunoreactive β-endorphin in normal human plasma. Journal of Clinical Investigation 62: 1395–1398 (1978).
Nakao, K.; Nakai, S.; Oki, S.; Matsubara, S.; Konishi, T.; Nishitani, H. and Imura, H.: Immunoreactive β-endorphin in human ccrebrospinal fluid. Journal of Clinical Endocrinology and Metabolism 50: 230–233 (1980).
Ngai, S.H.; Berkowitz, B.A.; Yang, J.C.; Hempstead, J. and Spector, S.: Pharmacokinetics of naloxone in rats and in man: Basis for its potency and short duration of action. Anesthesiology 44: 398–401 (1976).
Nicoll, R.A.; Siggins, G.R.; Ling, N.; Bloom, F.E. and Guilleman, R.: Neuronal actions of endorphins and enkephalins among brain regions: A comparative microiontophoretic study. Proceedings of the National Academy of Science USA 74: 2584–2588 (1977).
North, R.A. and Egan, T.M.: Actions and distributions of opioid peptides in peripheral tissues. Brit. Med. Bull. 39: 71–75 (1983).
Nutt, J.G. and Jasinski, D.R.: Methadone-naloxone mixtures for use in methadonc maintenance programmes. I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence. Clinical Pharmacology and Therapeutics 15: 156–166 (1974).
Odell, W.D.; Wolfsen, A.R.; Bachelot, I. and Hirose, F.H.: Ectopic production of lipotropin by cancer. American Journal of Medicine 66: 631 (1979).
Olson, G.A.; Olson. R.D.; Kastin, A.J. and Coy, D.H.: Endogenous opiates: 1980. Peptides 2: 349–369 (1981).
Olson, G.A.; Olson, R.D.; Kastin, A.J. et al.: Endogenous opiates: 1981 Peptides 3: 1039–1072 (1982).
O’Neill, P.J. and Rahwan, R.G.: Absence of formation of brain salsolinol in ethanol-dependent mice. Journal of Pharmacology and Experimental Therapeutics 200: 306–313 (1977).
Orwell, E.S. and Kendall, J.W.: β-Endorphin and adreno-corticotropin in extrapiluitary sites: Gastrointestinal tract. Endocrinology 107: 438–442 (1980).
Oyama, T.; Jin, T.; Yamaya, R.; Ling, N. and Gruillemin, R.: Profound analgesic effects of β-endorphin in man. Lancet I: 122–124 (1980).
Palmour, R.; Ervin, F.; Wagemaker, H. and Cade, R.: Characterization of a peptide from the serum of psychotic patients; in Usdin et al. (Eds) Endorphins in Mental Health Research, pp. 581–593 (Macmillan Press, London 1979).
Pardridge, W.M. and Mietus, L.J.: Enkephalin and blood-brain barrier: Studies of binding and degradation in isolated brain microvessels. Endocrinology 109: 1138–1143 (1981).
Pasqualucci, V.; Moricca, G. and Solinas, P.: Intrathecal morphine for the control of the pain of myocardial infarction. Anaesthesia 36: 68–69 (1981).
Paterson, S.J.; Robson, L.E. and Kosterlitz, H.W.: Classification of opioid receptors. British Medical Bulletin 39: 31–36 (1983).
Pert, C.B. and Snyder, S.A.: Opiate receptor: Demonstration in nervous tissue. Science 179: 1011–1014 (1973).
Peters, W.P.; Johnson, M.W.; Friedman, P.A. and Mitch, W.E.: Pressor effect of naloxone in septic shock. Lancet 1: 529–532 (1981).
Pickar, D. Vartunian, F. and Bunney, W.E.: Short-term naloxone administration in schizophrenic and manic patients. Archives of General Psychiatry 39: 313–319 (1982).
Polack, J.M.; Sullivan, S.N.; Bloom, S.R.; Facer, P. and Pearse, A.G.E.: Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet 1: 972–974 (1977).
Pollard, H.; Lorens-Cortes, C. and Schwartz, J.C.: Enkephalin receptors on dopaminergic neurones in rat striatum. Nature 268: 745–747 (1977).
Rapoport, S.I.; Klee, W.A.; Pettigrew, K.D. and Ohno, K.: Entry of opioid peptides into the central nervous system. Science 207: 84–86 (1980).
Reid, R.L. and Yen, S.S.C.: β-Endorphin stimulates the secretion of insulin and glucagon in humans. Journal of Clinical Endocrinology and Metabolism 52: 592–594 (1981).
Riggin, R.M. and Kissinger, P.T.: Determination of tetrahydroisoquinoline alkaloids in biological materials with high performance liquid chromatography. Analytical Chemistry 49: 530–533 (1977).
Rimon, R.; Terenius, L. and Kampman, R.: Cerebrospinal fluid endorphins in schizophrenia. Acta Psychiatrica Scandinavica 61: 395–403 (1980).
Rivier, C; Vale, W.; Ling, N.; Brown, M. and Guillemin, R.: Stimulation in vivo of the secretion of prolactin and growth hormone by β-endorphin. Endocrinology 100: 238–241 (1977).
Roberts, M.T. and Henderson, R.S.: Pituitary fossa injections with alcohol for widespread cancer pain. New Zealand Medical Journal 93: 1–3 (1981).
Ross, M.; Berger, P.A. and Goldstein, A.: Plasma β-endorphin immunorcactivity in schizophrenia. Science 205: 1163–1164 (1979).
Sawynok, J.; Pinsky, C. and La Bella, F.S.: Minireview on the specificity of naloxone as an opiate antagonist. Life Sciences 25: 1621–1632 (1979).
Schulz, R.; Whilhelm, A.; Pirke, K.M.; Gramsch, C. and Herz, A.: β-Endorphin and dynorphin control serum luteinizing hormone level in immature female rats. Nature 294: 757–759 (1981).
Schulz, S.C.; Van Kämmen, D.P.; Balow, J.E.; Flye, M.W. and Bunney, W.E.: Dialysis in schizophrenia: A double-blind evaluation. Science 211: 1066–1068 (1981).
Sharp, B. and Pekary, E.: β-Endorphin61-91 and other β-endorphin immunoreactive peptides in human semen. Journal of Clinical Endocrinology and Metabolism 52: 586–588 (1981).
Silbiger, M.L. and Donner, M.W.: Morphine in the evaluation of gastrointestinal disease. Radiology 90: 1086–1090 (1968).
Simon, E.J.; Hiller, J.M. and Edelman, I.: Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate. Proceedings of the National Academy of Science USA 70: 1947–1949 (1973).
Sjolund, B.H. and Eriksson, M.B.: The influence of naloxone on analgesia produced by peripheral conditioning stimulator. Brain Research 173: 295–301 (1979).
Snead, O.C. and Bearden, L.J.: Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. Science 210: 1031–1033 (1980).
Snyder, S.H.: Brain peptides as neurotransmitters. Science 209: 976–983 (1980).
Sorensen, S.C. and Mattison, K.: Naloxone as an antagonist in severe alcohol intoxication. Lancet 2: 688–689 (1979).
Stein, L. and Belluzzi, J.D.: Brain endorphins and the sense of well-being: A psychobiological hypothesis; in Costa and Trabucchi (Eds) Advances in Biochemical Psychopharmacology, Vol. 18, pp. 299–311 (Raven Press, New York 1978).
Symons, I.E.; Emson, P.C. and Farman, J.V.: Endogenous opioid poisoning? British Medical Journal 284: 469–470 (1982).
Taube, H.P.; Borowski, E.; Endo, T. and Starke, K.: Enkephalin: A potential modulator of noradrenaline release in rat brain. European Journal of Pharmacology 38: 377–380 (1976).
Terenius, L. and Wahlstrom, A.: Search for an endogenous ligand for the opiate receptor. Acta Physiologica Scandinavica 94: 74–81 (1975).
Terenius, L.; Wahlstrom, A.; Lindstrom, L. and Widerlov, E.: Increased CSF levels of endorphins in chronic psychosis. Neuroscience Letters 3 157–162 (1976).
Tolis, G.; Jukier, L; Guyda, H. and Krieger, D.: Effect of naloxone on adrenocorticotrophin. growth hormone and prolactin in patients with secretory pituitary tumours. Clinical Research 27: 261A (1979).
Tregear, G.W. and Coghlan, J.P.: Enkephalin, endorphin and the opiate receptor. Circ. Res. 46 (Suppl.): 142–148 (1980).
Tregear, G.W. and Coghlan, J.P.: Alcohol addiction: Are the endogenous opioids involved? Australian and New Zealand Journal of Medicine 11: 118–122 (1981).
van Rec, J.M.; de Wied, D.; Verhoeven, W.M. and van Praag, H.M.: Antipsychotic effect of β type endorphins in schizophrenia. Lancet 2: 1363–1364 (1980).
Verhoeven, W.M.A.; van Praag, H.M.; van Ree, J.M. and de Wied, D.: Improvement of schizophrenic patients treated with [Des-Tyr1]-β endorphin. Archives of General Psychiatry 36: 294–298 (1979).
Volavka, J.; Cho, D.; Mallya, A. and Bauman, J.: Naloxone increases ACTH and cortisol levels in man. New England Journal of Medicine 300: 1056–1057 (1979).
Wall, P.C. and Woolf, C.J.: What we don’t know about pain. Nature 287: 185–186 (1980).
Wallace, M.; Fraser, CD.; Clements, J.A. and Funder, J.W.: Naloxone, adrenalectomy and steroid replacement: Evidence against a role for circulating β-endorphin in food intake. Endocrinology 108: 189–192 (1981).
Wang, J.K.; Naus, L.A. and Thomas, J.E.: Pain relief by intrathecally applied morphine in man. Anaesthesiology 50: 149 (1979).
Wardlaw, S.L. and Frantz, A.G.: Measurement of β-endorphin in human plasma. Journal of Clinical Endocrinology and Metabolism 48: 176–180 (1979).
Watson, S.J.; Akil, H.; Ghazarossian, V.E. and Goldstein, A.: Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies. Proceedings of the National Academy of Science USA 78: 1260–1263 (1981).
Watson, S.J.; Akil, H.; Richard, C.W. and Barchas, J.D.: Evidence for two separate opiate peptide neuronal systems. Nature 275: 226–228 (1978).
Wesche, D.; Hollt, V. and Herz, A.: Radioimmunoassays of enkephalins. Regional distribution in rat brain after morphine treatment and hypophysectomy. Naunyn-Schmiedeberg’s Archives of Pharmacology 301: 79–82 (1977).
Yanagida, H.; Congenital insensitivity and naloxone. Lancet 2: 520–521 (1978).
Yen, S.S.C.; Lasley, B.L.; Wang, CF.; Leblanc, H. and Siler, T.M.: The operating characteristics of the hypothalamic-pituitary system during the menstrual cycle and observations of biological action of somatostatin. Recent Progress in Hormone Research 31: 321–357 (1975).
Zhang, A.Z. and Pasternak, G.W.: Mu and delta-opiate receptors: Correlation with high and low affinity opiate binding sites. European Journal of Pharmacology 67: 323–324 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Copolov, D.L., Helme, R.D. Enkephalins and Endorphins. Drugs 26, 503–519 (1983). https://doi.org/10.2165/00003495-198326060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198326060-00003